Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A.H. Robins Company was a prominent American pharmaceutical manufacturer known for developing and marketing iconic consumer healthcare brands such as Robitussin and ChapStick. Founded in 1866, the company grew into a major global player in the over-the-counter and prescription drug markets. However, it became embroiled in significant legal controversy during the 1970s and 1980s due to the Dalkon Shield intrauterine device, which led to thousands of personal injury lawsuits and the company's eventual bankruptcy. In 1989, A.H. Robins was acquired by American Home Products, which later became Wyeth and was subsequently absorbed by Pfizer. Today, many of its former products continue to be marketed under the Pfizer or Haleon umbrellas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Robins.